Inhibition of Urine 11-dH-TXB2 by Dihydroxyaluminum Aminoacetate-Heavy Magnesium Carbonate-Aspirin: A Long-term Result / 中国康复理论与实践
Chinese Journal of Rehabilitation Theory and Practice
; (12): 670-671, 2010.
Article
in Zh
| WPRIM
| ID: wpr-961568
Responsible library:
WPRO
ABSTRACT
@#Objective To evaluate the inhibition of urine 11-dH-TXB2 by dihydroxyaluminum aminoacetate-heavy magnesium carbonate-aspirin in Chinese cardiovascular patients after long-term therapy. Methods103 cardiovascular patients were treated with oral doses of dihydroxyaluminum aminoacetate-heavy magnesium carbonate-aspirin tablets (162 mg aspirin) daily for 24 weeks. The Urine 11-dH-TXB2 concentration were measured before and 6, 12, 24 weeks after administration. ResultsThe urine 11-dH-TXB2 concentration were (1840.41±1452.63) pg/ml, (820.01±610.55) pg/ml, (1011.19±1148.12) pg/ml, (1290.82±1425.51) pg/ml before and 6, 12, 24 weeks after administration. The urine 11-dh-TXB2 concentration was higher in 24th week than in 12th weeks and 6th week. ConclusionThe dihydroxyaluminum aminoacetate-heavy magnesium carbonate-aspirin can inhibit the platelet aggregation, which decreased after long-term administration.
Full text:
1
Database:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Rehabilitation Theory and Practice
Year:
2010
Document type:
Article